Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,674 INR | +0.99% | +1.59% | +3.74% |
May. 14 | Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR2,713 From INR2,505 | MT |
May. 13 | Dr. Lal Pathlabs' Fiscal Q4 Consolidated Net Profit Rises; Share Up 6% | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.74% | 2.63B | |
-25.47% | 7.76B | |
+69.31% | 4.33B | |
-3.33% | 2.64B | |
-47.63% | 2.16B | |
-16.44% | 1.75B | |
-19.40% | 1.46B | |
+14.52% | 1.17B | |
-45.53% | 1.14B | |
+19.68% | 999M |
- Stock Market
- Equities
- LALPATHLAB Stock
- News Dr. Lal PathLabs Limited
- Transcript : Dr. Lal PathLabs Limited, Q4 2024 Earnings Call, May 10, 2024